Stocks · Health care · Pharmaceutical Preparations

Dermata Therapeutics, Inc.

DRMA Clue Score42
United States Fiscal year ends December CIK 0001853816 Results filed 11 Aug 2026

What the insiders did No buying or selling

By person

6 insiders · 0 transactions
1.2×

Gerald T. Proehl holds only 1.2 times base salary in stock. $348.26K of shares against $280.00K in salary for 2025.

Salary from the company's own proxy. The shares are what Gerald T. Proehl last reported holding, valued at $1.19, the price Common Stock was last bought or sold at on the open market here, on 16 Jun 2026.

Insider
Role
Bought
Sold
Net
Holding
Worth
Change
Gerald T Proehl
President, Chairman, CEO
—
—
—
292,631
$348.26K
—
Hoose Kyri K. Van
SVP, CFO
—
—
—
232,463
$276.65K
—
Mary Fisher
Director
—
—
—
196,946
$234.39K
+207,212%
David F Hale
Director
—
—
—
80,957
$96.35K
+3,553%
Munera Maria E Bedoya-Toro
SVP, Regulatory Affairs
—
—
—
1,012
$1.20K
+8,333%
Kathleen D. Scott
Director
—
—
—
0
$0.00
−100.0%

No percentages here. This company's share count has moved by a factor of 8.0 over the window, from 681,557 to 5,430,648 shares. A split, a merger or a large issue changes what the company is, and a holding measured at one point in that run is not a fraction of it at another.